Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

“Unusual Cause Of Tophi With Renal Thrombotic Microangiopathy”

Authors: Kamal Kant Sahu, Arjun Datt Law, Ganesh Kumar, Varun Dhir, Shano Naseem, Ritambhra Nada, Subhash Chander Varma, Pankaj Malhotra

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Chronic neutrophilic leukemia (CNL) is a rare entity amongst myeloproliferative neoplasms (MPNs). The classical presentation of CNL is with splenomegaly, mature neutrophilic leucocytosis and hyperuricemia. We herein report a case who presented with symptoms of acute gouty arthritis. Physical examination showed typical red, tender tophi in the right hand, right foot and both pinnae suggesting an acute episode of gout. During evaluation, moderate splenomegaly, mature neutrophilia, hyperuricemia and sub-nephrotic range range proteinuria were noted. Bone marrow examination and kidney biopsy was done. Final diagnosis of CNL with acute gouty arthritis and chronic renal thrombotic microangiopathy (TMA) was made. Although hyperuricemia is a common finding in MPNs but presentation of our case with symptoms of acute tophi and chronic TMA is atypical.
Literature
1.
go back to reference Tuohy EL (1920) A case of splenomegaly with polymorphonuclear neutrophil hyperleukocytosis. Am J MedSci 160:18–25CrossRef Tuohy EL (1920) A case of splenomegaly with polymorphonuclear neutrophil hyperleukocytosis. Am J MedSci 160:18–25CrossRef
2.
go back to reference Tanzer J, Harel P, Boiron M, Bernard J (1964) Cytochemical and cytogenetic findings in a case of chronic neutriphilic leukaemia of mature cell type. Lancet 1(7329):387–388CrossRefPubMed Tanzer J, Harel P, Boiron M, Bernard J (1964) Cytochemical and cytogenetic findings in a case of chronic neutriphilic leukaemia of mature cell type. Lancet 1(7329):387–388CrossRefPubMed
3.
go back to reference Reilly JT (2002) Chronic neutrophilic leukaemia: a distinct clinical entity? Br J Haematol 116(1):10–18CrossRefPubMed Reilly JT (2002) Chronic neutrophilic leukaemia: a distinct clinical entity? Br J Haematol 116(1):10–18CrossRefPubMed
4.
go back to reference Bohm J, Schaefer HE (2002) Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease. J Clin Pathol 55(11):862–864 Epub 2002/10/29CrossRefPubMedPubMedCentral Bohm J, Schaefer HE (2002) Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease. J Clin Pathol 55(11):862–864 Epub 2002/10/29CrossRefPubMedPubMedCentral
5.
go back to reference Meyer S, Feremans W, Cantiniaux B et al (1993) Successful alpha-2b-interferon therapy for chronic neutrophilic leukaemia. Am J Hematol 43:307–309CrossRefPubMed Meyer S, Feremans W, Cantiniaux B et al (1993) Successful alpha-2b-interferon therapy for chronic neutrophilic leukaemia. Am J Hematol 43:307–309CrossRefPubMed
6.
go back to reference Bardy A, Tiple A, Rabant M, Kemeny JL, El Karoui K, Hermet M et al (2014) The myeloproliferative neoplasms-related glomerulopathy. Rev Med Interne 35(4):222–230CrossRefPubMed Bardy A, Tiple A, Rabant M, Kemeny JL, El Karoui K, Hermet M et al (2014) The myeloproliferative neoplasms-related glomerulopathy. Rev Med Interne 35(4):222–230CrossRefPubMed
7.
go back to reference Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP et al (2011) Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 80(7):753–759CrossRefPubMed Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP et al (2011) Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 80(7):753–759CrossRefPubMed
Metadata
Title
“Unusual Cause Of Tophi With Renal Thrombotic Microangiopathy”
Authors
Kamal Kant Sahu
Arjun Datt Law
Ganesh Kumar
Varun Dhir
Shano Naseem
Ritambhra Nada
Subhash Chander Varma
Pankaj Malhotra
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0539-9

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine